From: Correlation of anti-fungal susceptibility with clinical outcomes in patients with cryptococcal meningitis
Anti-fungal agent
Cumulative % inhibited at MIC (μg/ml)
0.06
0.12
0.25
0.5
1
2
4
8
16
32
Amphotericin B
0
6.5
36.9
82.6
100
Fluconazole
8.7
28.3
74
95.7
Voriconazole
52.2
91.3